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Abstract
Infectious intestinal disease (IID), with associated high 
morbidity and considerable mortality worldwide, causes a 
wide spectrum of illness.  This ranges from mild discomfort 
to illness with severe complications.  The economic burden 
from direct and indirect costs may be high.  It is acquired by 
oral ingestion of micro-organisms which are transmitted from 
person to person; via food or water or through contact with 
animals or contaminated objects.  Viruses are the commonest 
cause in developed countries.  In Malta, medical practitioners 
and laboratories are the main source of data on IID.  However, 
under-reporting is a problem.  In order to fill in the lacunae in 
information on the disease burden, population-based-studies 
are required.  Along with other countries,  Malta has embarked 
on a number of studies to describe and quantify under-reporting 
of IID. This may assist in strengthening the surveillance system 
which, in combination with other measures, should result in an 
improvement of the control of IID.
* corresponding author
Introduction
The term infectious intestinal disease (IID) is used to 
describe gastrointestinal symptoms (diarrhoea, vomiting and 
abdominal pain) due to micro-organisms or their toxins.  It is one 
of the leading causes of morbidity and mortality worldwide.1-3  In 
less developed countries, the mortality rate from this category 
of disease is slowly decreasing but the incidence remains very 
high.4-5  In more developed countries, improvements in hygiene 
and treatment of disease have radically reduced the number of 
deaths while the clinical course is often self-limiting.  However, 
the morbidity remains high.6
IID causes a wide spectrum of diseases ranging from minor 
discomfort to extreme dehydration which may result in death. 
Most episodes are self limiting.  However, some may lead to 
complications.  It has been estimated that 2-3% of IID cases 
develop a variety of secondary long term illnesses.7  The most 
recognised of these are irritable bowel syndrome,8-9 Guillain-
Barré syndrome,10-11 reactive arthritis and haemolytic uraemic 
syndrome.12-13
 The economic burden of IID to society is high.14-16    There 
are direct costs involved which include those relating to general 
practitioner (GP) consultations, laboratory tests,  hospital 
admissions and medications.  Indirect costs include losses in 
income and productivity.17
Aetiology of infectious intestinal illness
IID is acquired predominantly by oral ingestion of micro 
organisms or their toxins.  They are transmitted by close 
contact with other infected persons; by the consumption of 
contaminated food or water; through contact with animals or by 
contact with contaminated objects (fomites).18  Some pathogens 
are associated with a specified mode of transmission such as 
the rotavirus which is mainly non-foodborne.  However, most 
pathogens have multiple modes of transmission (Table 1). 
Viral infections are the commonest cause of IID in the 
community.  Noroviruses are suspected to be the most common 
cause in the United States.19  Other viruses include rotavirus,20 
sapovirus, adenovirus and astrovirus.  The commonest bacterial 
agents responsible for IID are Campylobacter and Salmonella. 
Other bacteria include Escherichia coli, Shigella, Staphylococcus 
aureus, Bacillus cereus and Yersinia. The main protozoa causing 
infectious intestinal disease are Cryptosporidium and Giardia 
lamblia.21
In Malta, Salmonella was the commonest identifiable 
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Micro-organism Common sources Symptoms of infection
Campylobacter Eating contaminated meat (especially  Often bloody, sometimes watery diarrhoea
 undercooked poultry); drinking contaminated  lasting 1 day to a week or more
 water or unpasteurised milk
 
Salmonella Eating contaminated food, contact with  High fever, abdominal cramps, nausea, vomiting, 
 reptiles (iguanas, snakes, turtles) diarrhoea that may or may not be bloody.
    Symptoms usually last 3 to 7 days
   
Shigella Person-to-person contact, May be mild or severe.  In mild cases, watery, 
 especially in day-care centres loose stools.  In severe cases, high fever, severe
  abdominal cramps, painful passage of stool
  containing blood and mucus.  Symptoms usually
  last about a week without treatment
   
Escherichia coli Eating undercooked ground beef or drinking  Sudden abdominal cramps, watery diarrhoea
O157:H7 unpasteurised milk or  juice; swimming in  that usually becomes bloody within 24 hours, 
 contaminated pools; person-to-person  haemolytic-ureamic syndrome
 contact; touching infected animals  fingers in one’s mouth
 and then putting 
 
Entamoeba  Eating or drinking contaminated  Bloody diarrhoea, abdominal pain, weight loss
histolytica food or water lasting 1 to 3 weeks.  Can cause infection in liver
  and other organs
  
Enterotoxigenic  Eating or drinking contaminated  Frequent watery diarrhoea.  
E. coli food or water Usually lasts 3 to 5 days
  
Vibrio cholerae Eating or drinking contaminated  Painless, watery diarrhoea; vomiting.  
 food or water Can lead to massive fluid loss, shock.
  
Other types  Shellfish Watery, diarrhoea, often with little 
of Vibrio  nausea or vomiting
Staphylococcus  Eating food contaminated by toxins  Severe nausea and vomiting beginning about
aureus produced by bacteria 2 to 8 hours after eating contaminated food
  
Clostridium  Eating food contaminated by  Usually mild.  When severe, abdominal
perfringens toxins produced by bacteria pain, abdominal expansion, severe diarrhoea,
  dehydration, shock.  Symptoms usually begin 
  8 to 16 hours after eating contaminated food
  
Viral infections  Epidemic and often seasonal Frequent watery diarrhoea; vomiting and fever
(rotaviruses,   (milder in astroviruses).  Usually lasts 2 to 7 days
norovirus,   (10 days or more for enteric adenoviruses)
astroviruses, 
enteric 
adenoviruses)
  
Giardia Drinking contaminated stream water;  Diarrhoea, nausea, loss of appetite.  
 person-to-person contact, particularly  More long-term illness (lasting several
 in day-care centres days to several weeks) may occur, with grassy
  stools, abdominal bloating, gas, and weight loss
   
Crytosporidium Drinking contaminated water;  Watery diarrhoea, crampy abdominal pain, 
 person-to-person contact.  People with AIDS  nausea, vomiting
 are particularly susceptible
Table 1: Micro-organisms known to cause IID, their source and symptoms
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Figure 1: Reported sporadic foodborne illness 
in Malta 1992-2005 by aetiological agent
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Figure 2: The reporting fraction of IID in Malta
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pathogen in cases of IID over recent years up to 2003.  However, 
as of 2004 the number of reported cases of Campylobacter is 
higher than that for Salmonella.22  A substantial number of 
notified cases in the same year are still defined as unspecified 
where the aetiological agent has not been identified (Figure 1).23 
In these cases, the pathogen may not identified.  Alternatively 
it may well be a pathogen not yet identified.  These will become 
apparent with time and investigation.
It may well be that the majority of the cases labelled as 
unspecified in Malta are of viral origin, since tests for viruses 
are not routinely used and particularly the laboratory test for 
norovirus is not available locally  to date.
Sources of information on infectious 
intestinal illness in Malta
In Malta, a small island state with traditionally strict 
infectious disease legislation, surveillance of infectious 
diseases dates back over a century.  During the 19th century, the 
importance of improving the sanitary condition of the Island was 
highlighted through a number of legal ordinances introduced 
in 1875.  The Sanitary Office was set up through these laws and 
was responsible for, amongst other public health issues, the 
investigation and control against infective diseases and for the 
keeping of statistics.24  Today, the Disease Surveillance Unit, 
within the Public Health Department, is responsible for the 
surveillance of infectious intestinal disease.  This unit receives 
notifications from general practitioners, hospital physicians 
and laboratories. The majority of notifications received include 
cases, which required hospitalisation or referral for stool culture 
analysis.  Notifications from general practitioners are very few 
even though these have a statutory obligation to notify.  To be 
included in the present surveillance system, an individual must 
first present to the health care provider who should notify the 
case. Of those that present to the health care provider, only a 
small proportion of  specimens are submitted for microbiological 
testing. Naturally, only the severe cases would require 
hospitalisation.  Hence, the surveillance system captures only 
a tiny fraction of the infectious intestinal disease that is actually 
occurring in the community.  This indicates that there must be 
significant lacunae in information describing the magnitude of 
infectious intestinal disease, especially at the population level. 
Figure 2 represents the relatively unknown quantity of IID and 
an undefined portion that is reported. 
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The international situation
The problem of under-reporting is a recognised problem 
internationally.25-30  In order to better estimate the burden 
associated with IID, research is required to provide information 
to base estimates.    A number of international initiatives have 
been designed to determine the burden of disease.
WHO Global Salm-Surv.  This an international capacity-
building programme which strengthens national laboratory-
based surveillance and outbreak detection of diseases commonly 
transmitted via food.31
WHO Sentinel Sites Project.  This project defined 
surveillance systems in four categories based on the ability 
of the system to generate information on foodborne illness.32 
Category 1 included countries where no formal surveillance 
existed; Category 2 included countries with syndromic 
surveillance; Category 3 included countries with laboratory-
based surveillance and Category 4 included those with integrated 
food-chain surveillance.  The countries with Category 3 and 4 
surveillance systems were recommended for burden studies. 
Jordan was chosen as the first sentinel site for this project.  
 International Collaboration on enteric diseases: 
the Burden of Illness Studies.  This was set up to bring 
epidemiologists conducting population studies together to 
share information and collaborate on international studies.33 
This network includes researchers from more than 30 countries 
amongst which are the United States, Canada, Australia, Ireland, 
Scotland, the United Kingdom, Japan, the Netherlands and 
Malta who are performing studies in an attempt to estimate 
the actual burden from IID.  The main aims of this network 
are to: 
• Foster communication between researchers via a list-
server, conference calls, and an annual face-to face-
meeting.
• Create a forum for sharing information about the design, 
implementation and analysis of studies on the burden of 
illness.
• Provide advice to countries wishing to conduct burden of 
illness studies.
• Contribute to global estimates.
A number of countries have undertaken national initiatives 
in estimating the burden of infectious intestinal disease.  The 
first countries to embark on community studies to estimate the 
burden of IID were England, The Netherlands and the United 
States.25, 34-37  After this a number of other countries conducted 
similar studies.  Some researchers used a prospective cohort 
study whilst others used a retrospective cross-sectional study.  
England. A prospective population cohort study was 
performed in England over the period 1993-1995.25, 38-39  Cohorts 
from 70 general practices were recruited and stool samples were 
obtained and tested for bacteria, viruses and parasites.  It was 
estimated that 19.4% (CI ± 2.7) of the population of England 
suffered from IID in a year and 3.3% of the population presented 
to their GP with IID.  The most common aetiologic agents were 
norovirus, Campylobacter species, rotavirus, and non-typhoidal 
Salmonella species.  
The Netherlands. A similar study was carried out in the 
Netherlands during the period 1998-1999 where 60 practitioners 
reported the number of consultations for acute gastroenteritis 
that occurred each week.  An age-stratified random sample of 
patients identified from the same registers was selected for a 
community-based cohort.  This provided an estimate of 28.3% 
(CI ± 6.3) of the population suffered from gastroenteritis36 and 
1.4% consulted their GP.35  This study also investigated a broad 
range of pathogens causing gastroenteritis.9 The most common 
pathogen at community level was norovirus (11%).21 
United States.  The FoodNet population survey, 
established in 1996 out as part of CDC’s Emerging Infectious 
Programme is based on retrospective self-reported symptoms.37 
During 1996-1997, this survey reported 11.0% (CI ± 0.8) of the 
people suffering from diarrhoeal illness in the 4 weeks before 
the interview.
Ireland.  A retrospective telephone study of self-reported 
symptoms of gastroenteritis that was performed during the 
period 2000 to 2001 in Ireland estimated that 4.5% (CI ± 0.8) 
of the population reported suffering from acute gastroenteritis 
in the 4 weeks prior to the interview with a rate of 0.60 episodes 
per person per year.40-41  
Australia. A retrospective study conducted in Queensland 
in 2001 via OzFoodNet,   estimated that 13.6% (CI ± 2.4) of the 
adult cases (18 years or older) and 13.9% (CI ± 8.1) of children 
(7 months to 4 years) reported diarrhoea in the preceding 
month.42
Canada. The National Studies on acute gastrointestinal 
Illness conducted a retrospective population based study 
which estimated a monthly prevalence of 10% and an adjusted 
incidence rate of 1.3 episodes per person per year.43 
 Norway. A retrospective population-based study was 
carried out in 1999-2000 using a self-administered postal 
questionnaire.  The prevalence of acute gastroenteritis was 
14.4% (CI ± 2.6) of which 17% consulted a physician.44
 
Situation in Malta
Information on the burden of IID illness is lacking in 
Malta.  Various issues were considered in the choice of the 
methodology for a possible exploratory study.45 A cohort study 
is not applicable in a country like Malta where no general 
practitioner based patient lists exist, with patients referring to 
any doctor they wish and hence, a doctor would not be able to 
follow up patients prospectively.  Hence, a cross sectional study 
was chosen as the method to estimate the prevalence of IID 
in Malta. The advantages of the cross-sectional methodology 
include the fact that it is less expensive and can be performed 
more quickly, enabling a larger sample size, hence, decreasing 
Type II error*.  Attrition of participants is not a concern and 
there is no difficulty and cost in maintaining contact with the 
* Type II error:  the error of rejecting a true null hypothesis i.e. 
declaring that a difference exists when it does not.
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subjects since they are not followed up.  Another factor is that 
this type of study can capture community cases, since it does 
not rely on persons presenting to their GP.  There are a number 
of disadvantages to this approach which includes difficulty 
in separating the chronology of cause and effect because of 
the short time studied and the inherent biases (selection, 
confounding and information bias).  
Four studies have been launched in Malta in order to 
estimate the incidence of infectious intestinal disease at various 
levels and to identify where and how cases are lost along the 
surveillance chain. These include:
1. A Community based survey interviewing an age-
stratified random sample of the population to estimate 
the baseline incidence of self-reported infectious 
intestinal disease in the community and to estimate the 
proportion of cases which do not present to the health 
care system and are notified, thereby quantifying under-
reporting of infectious intestinal disease.
2. A Sentinel Surveillance study consisting of 
intensified surveillance by a number of GPs for a defined 
period of time in order to estimate the true number of 
cases presenting to GPs with IID and to test the feasibility 
of carrying out sentinel surveillance in Malta.
3. A Knowledge, Attitude and Practice survey of 
physicians consisting of a focus study and a postal 
survey of a sample of local physicians to assess their 
attitudes and awareness of the notification system in 
order to identify the reasons behind under-notification 
or delayed notification, with a view to developing 
recommendations aimed at reducing this problem.
4. A Laboratory Study consisting of interviews at local 
laboratories to identify practices in laboratories that 
impact on the sensitivity of finding an aetiologic agent in 
submitted stool specimens and their attitudes towards 
notification.
Conclusion
In a small island state such as Malta, the epidemiology of 
infectious disease ought to be more practical and complete. 
Describing and quantifying under-reporting may assist in 
strengthening the surveillance system of IID by: 
a) identifying where and how cases are lost along the 
surveillance chain
b) finding ways to reduce loss of data and 
c) developing correction factors to compensate for a known 
magnitude of under reporting.
Strengthening the national surveillance system in 
combination with other measures should result in a marked 
improvement in the ability to detect, investigate and control 
food and water-borne enteric pathogens.
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